Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center shared a post on X:
“Exciting and Engaging Leukemia Research Meeting Talk on Blastic plasmacytoid dendritic cell neoplasm (BPDCN) by Dr. Naveen Pemmaraju today. SL-401, IMGN 632 and other exciting CD123 targeting agent. Newer targets and better treatment options. Success from collaborative efforts and team work Rare disease framework.”
Source: Jayastu Senapati/X
